CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Protagonist upgraded at Goldman Sachs on potential of autoimmune asset

Positive
AI Analysis

Summary

Goldman Sachs upgraded Protagonist Therapeutics, citing the potential of the company's autoimmune asset.

Importance:4/10
Sentiment:
0.60
analyst upgradeautoimmunePTGX
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 10, 2026 3:42 PM

Read Original